A Phase 2 Trial of CD24Fc for Prevention of Graft-vs-Host Disease.

Magenau JM, Jaglowski SM, Uberti J, Farag SS, Riwes MMansour, Pawarode A, Anand S, Ghosh M, Maciejewski J, Braun TM, et al. A Phase 2 Trial of CD24Fc for Prevention of Graft-vs-Host Disease. Blood. 2023.